After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Lexeo Therapeutics Inc is $84.65M. A total of 0.68 million shares were traded on the day, compared to an average of 706.24K shares.
In the most recent transaction, Townsend Richard Nolan sold 4,326 shares of LXEO for 4.41 per share on Feb 19 ’25. After the transaction, the Chief Executive Officer now owns 220,119 company shares. In a previous transaction on Feb 19 ’25, See Tai Sandi sold 1,486 shares at 4.41 per share. LXEO shares that Chief Development Officer owns now total 53,889.
Among the insiders who sold shares, Adler Eric disposed of 2,359 shares on Feb 19 ’25 at a per-share price of $4.41. This resulted in the Chief Medical Officer holding 68,266 shares of LXEO after the transaction. In another insider transaction, Robertson Jenny sold 2,101 shares at $4.41 per share on Feb 19 ’25. Company shares held by the Chief Legal Officer now total 57,899.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, LXEO has a high of $19.50 and a low of $1.45.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. LXEO’s latest balance sheet shows that the firm has $135.86M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $7.45M in liabilities at the time. Its Book Value Per Share was $3.53, while its Total Shareholder’s Equity was -$55.60M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXEO is Buy with a score of 4.86.
